Horsman M R, Ehrnrooth E, Ladekarl M, Overgaard J
Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus University Hospital.
Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):895-8. doi: 10.1016/s0360-3016(98)00299-5.
To investigate the activity of combretastatin A-4 disodium phosphate in a transplanted C3H mouse mammary carcinoma and several murine spontaneous tumors.
The C3H mammary carcinoma was grown in the right rear foot of female CDF1 mice and treated when 200 mm3 in size. Spontaneous tumors (341-1437 mm3 in size) arose at different sites in female CDF1 mice that, 19-21 months earlier, had been irradiated. Oxygen partial pressure (pO2) distributions in the C3H tumors were measured with an Eppendorf oxygen electrode at various times after injecting combretastatin (100 mg/kg, i.p.) in restrained, nonanesthetized mice. Immediately after measurement, tumors were excised and necrotic fraction determined from histological sections. In the spontaneous tumors, pO2 was measured before and 3 h after giving combretastatin. The location of these spontaneous tumors required that measurements be made in anesthetised animals, achieved by injecting a mixture of hypnorm and diazepam.
In untreated C3H tumors, the mean (+/- 1 SE) percentage of pO2 values < or = 2.5 mmHg was 32% (+/- 11). This was significantly (Student's t-test; p < 0.05) increased to 74% (+/- 4) within 1 h after injecting combretastatin, and remained at this level for at least 6 h, although some recovery was seen at 12 and 24 h. The necrotic fraction in control tumors was 1.9% (+/- 0.4) and this was significantly increased to 16.1% (+/- 3.7) 24 h after drug administration. In spontaneous tumors, the pO2 measurements indicated that 5 of 6 showed some response to combretastatin, although the degree of change was variable.
Combretastatin increased tumor hypoxia and necrosis in the C3H mammary carcinoma, consistent with the induction of vascular damage. Drug-induced changes in pO2 were also found in spontaneous tumors, suggesting that the activity of this drug is not restricted to transplanted tumors alone.
研究磷酸羟基喜树碱在移植的C3H小鼠乳腺癌及几种小鼠自发性肿瘤中的活性。
将C3H乳腺癌接种于雌性CDF1小鼠的右后足,肿瘤体积达200 mm3时进行治疗。自发性肿瘤(体积为341 - 1437 mm3)出现在19 - 21个月前接受过照射的雌性CDF1小鼠的不同部位。在未麻醉的受限小鼠腹腔注射磷酸羟基喜树碱(100 mg/kg)后的不同时间,用Eppendorf氧电极测量C3H肿瘤中的氧分压(pO2)分布。测量后立即切除肿瘤,通过组织学切片确定坏死分数。在自发性肿瘤中,在给予磷酸羟基喜树碱之前和之后3小时测量pO2。这些自发性肿瘤的位置需要在麻醉动物中进行测量,通过注射海俄普和地西泮的混合物来实现。
在未治疗的C3H肿瘤中,pO2值≤2.5 mmHg的平均(±1 SE)百分比为32%(±11)。注射磷酸羟基喜树碱后1小时内,该值显著(Student's t检验;p < 0.05)增加至74%(±4),并至少维持6小时,尽管在12小时和24小时观察到一些恢复。对照肿瘤的坏死分数为1.9%(±0.4),给药后24小时显著增加至16.1%(±3.7)。在自发性肿瘤中,pO2测量表明6个中有5个对磷酸羟基喜树碱有某种反应,尽管变化程度各不相同。
磷酸羟基喜树碱增加了C3H乳腺癌中的肿瘤缺氧和坏死,这与血管损伤的诱导一致。在自发性肿瘤中也发现了药物诱导的pO2变化,表明该药物的活性并不局限于移植性肿瘤。